The program helped me think outside the box in performing my daily tasks and enabled me to be a change leader in my current job and other functions that I move into. The lecturers kept the entire class active and captivated.

[Read More]

BUSINESS | Mini-MBA™: BioPharma Innovation

Mini-MBA™: BioPharma Innovation

Format:
Twelve 3-hour modules. Must attend a Minimum of 10 sessions to earn a certificate

Participant Profile:
Scientists and business professionals in Biotech and Pharma seeking to gain greater industry-specific skills and prepare for a broader, more strategic role in their organization

Individuals considering an MBA or Professional Science Master’s degree that combines advanced science and business

Credit Available:
3 graduate-level credit waiver upon passing an optional final exam. Credits apply to applicants meeting entrance requirements to the MBA program at Rutgers Business School

Cost:
$4,995 includes all instructional materials and fees. Ask about team discounts and Rutgers Alumni discount

Faculty:
Leading professors from Rutgers Business School, the School of Management and Labor Relations, Rutgers Law School, and industry experts in the areas of Biotech and Pharmaceuticals

Program Overview
While pharmaceutical innovation has improved the quality of life, there remains a wide range of challenges facing the industry. The Rutgers Mini-MBA™: BioPharma Innovation program explores new business models and the vision required to address these challenges. Learning is focused on building business skills tailored to the needs of the Biotech and Pharmaceutical industries, while challenging participants to consider new business paradigms promoting sustainable revenue growth, stakeholder cooperation, and cost management in a capstone session.

Who Should Attend?
The Mini-MBA™: BioPharma Innovation is a certificate program for:

Science or business professionals in the biotech or pharmaceutical industries desiring to enhance their business acumen and improve their ability to work across functions in their organizations
Company teams or cross-functional groups who are seeking to leverage the value of new learning tools and resources throughout the organization
Leaders who have been promoted into commercial roles from functional, medical, chemical or engineering backgrounds
Senior Scientists making the transition into management positions
Students pursuing advanced study and contemplating careers in the bioscience sector (MD, PhD)

Skills You Will Acquire
This program provides participants with an understanding of:

A new vision for pharmaceutical business modeling based on cooperation between healthcare stakeholders and patient outcomes
How strategies for the discovery, analysis and approval of new drugs are developed
Intellectual property laws and government policies driving drug development decisions
The clinical/regulatory process and timelines at the US FDA and its foreign counterparts
How potential therapeutic areas for pharmaceutical intervention are identified, researched and analyzed
How to construct written/oral reports for drug development and marketing

After completing the program, participants will be familiar with how key functions work together to develop a successful drug, as well as how researching, modeling, and projecting market opportunities for specific therapeutic areas create future market opportunities.

Curriculum
The Rutgers Mini-MBA™: BioPharma Innovation features focused learning experiences and case studies on vital subject areas in today’s rapidly changing industry environment. Twelve sessions are delivered in three-hour modules. To see a detailed description of the program, please download the program brochure.Topics may include:

STRATEGY AND CONTEXT

Globalization & Innovation: New Technologies, New Talent, Successful Strategies & Future Challenges
The Economic Policy Context
Innovation in the BioPharma Industry
The FDA & the Regulatory Process
Understanding the Marketplace: Evolving Healthcare Systems in the US & Abroad

FINANCIAL ANALYSIS